Schedule 13G ownership disclosure

Lexicon Pharmaceuticals Inc

Security class unavailable · CUSIP: 528872302

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
10,426,793
Percent of class
10.0600%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000861177-16-000026
Form type
SC 13G
Filer
LEXICON PHARMACEUTICALS, INC.
CIK
CIK 1062822
Filed
Feb 16, 2016
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub